After Hours
There is a slight risk associated with trading before and after the market open. Due to lower liquidity and higher volatility, extended-hours trading may result in wider spreads on particular security due to the release of critical financial information after regular trading hours. Yahoo Finance discussed the stock recently as it posted Avadel Pharmaceuticals to Present at Upcoming Investor Conferences.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Stocks Info
This NASDAQ-listed company operates within the Drug Manufacturers – Specialty & Generic industry segment, falling under the Healthcare sector. The current market capitalization of Avadel Pharmaceuticals plc ADR is $1.49B. A total of 0.78 million shares were traded on the day, compared to an average of 1.31M shares.
In the most recent transaction, MCHUGH THOMAS S bought 2,000 shares of AVDL for 14.50 per share on Jan 16 ’24. After the transaction, the Chief Financial Officer now owns 80,500 company shares. In a previous transaction on Dec 28 ’23, McCamish Mark Anthony sold 75,000 shares at 14.53 per share. AVDL shares that Director owns now total 67,025.
Among the insiders who bought shares, MCHUGH THOMAS S acquired of 2,000 shares on Aug 14 ’23 at a per-share price of $14.45. This resulted in the Chief Financial Officer holding 78,500 shares of AVDL after the transaction. In another insider transaction, McCamish Mark Anthony sold 28,975 shares at $14.93 per share on Aug 11 ’23. Company shares held by the Director now total 142,025.
Even though price targets are rarely accurate, they do tend to exert some kind of influence from time to time and are often considered important by markets. In terms of 52-week highs and lows, AVDL has a high of $17.44 and a low of $8.00.
As of this writing, AVDL has an earnings estimate of -$0.21 per share for the current quarter. EPS was calculated based on a consensus of 9 estimates, with a high estimate of -$0.02 per share and a lower estimate of -$0.31. The company reported an EPS of -$0.41 in the last quarter, which was -10.80% lower than expectations of -$0.37.
Balance Sheet Annually/Quarterly
In a balance sheet, you can see what assets and liabilities the company has, as well as how much equity investors have invested. These figures can be used to calculate a company’s financial ratios to give investors a better idea of its prospects. AVDL’s latest balance sheet shows that the firm has $157.22M in Cash & Short Term Investments as of fiscal 2021. There were $145.00M in debt and $21.00M in liabilities at the time. Its Book Value Per Share was $0.92, while its Total Shareholder’s Equity was $78.24M.
Analysts Opinion
The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for AVDL is Buy with a score of 4.90.
